Abstract | INTRODUCTION: DESIGN: A single-center, retrospective review was conducted on 141 recipients transplanted from January 2011 to December 2015. Transplant recipients were characterized by age <60 years (n = 94) or age 60 years and older (n = 47) for analysis. RESULTS: A greater incidence of leukopenia was seen in the older cohort compared to the younger cohort (64% vs 55%). Of those patients who developed leukopenia, the older cohort ( n = 30) had a higher incidence of hospitalization for leukopenia (30% vs 23%) but a lower incidence of hospitalization for infection (20% vs 25%) compared to the younger cohort (n = 52). Additionally, one month following mycophenolate mofetil (MMF) discontinuation, the older cohort had reduced recovery of their white blood cell count (+263.8% vs +272.5%) and experienced less recurrent leukopenic episodes (50% vs 67%) and rejection episodes (0% vs 22%) compared to the younger cohort, alluding to the need for less immunosuppression. CONCLUSIONS:
|
Authors | Yanmen Yang, Christina M Guerra, Nabil Sumrani |
Journal | Progress in transplantation (Aliso Viejo, Calif.)
(Prog Transplant)
Vol. 29
Issue 1
Pg. 54-60
(03 2019)
ISSN: 2164-6708 [Electronic] United States |
PMID | 30514165
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Adult
- Age Factors
- Aged
- Female
- Humans
- Incidence
- Kidney Transplantation
- Leukopenia
(epidemiology, etiology)
- Male
- Middle Aged
- Mycophenolic Acid
(administration & dosage)
- New York City
(epidemiology)
- Postoperative Complications
(epidemiology, etiology)
- Retrospective Studies
|